基于网络药理学方法揭示山茱萸作用于骨质疏松的机制
Study on Mechanism of Cornus officinalis against Osteoporosis Based on Network Pharmacology
摘要: 目的:基于网络药理学与生物信息学方法筛选山茱萸有效活性成分和潜在作用靶点,构建山茱萸活性成分–作用靶点网络图及蛋白互相作用(protein-protein-interaction network, PPI network)网络图。方法:通过中药系统药理学数据库(TCMSP)检索山茱萸主要活性成分及其潜在的作用靶点,通过OMIM和Genecards数据库检索骨质疏松相关靶点基因,利用R软件绘制山茱萸靶点基因与骨质疏松靶点基因的韦恩图。利用Cytoscape3.7.2筛选核心网络,通过STRING数据库构建PPI网络,并进行GO功能、KEGG通路的富集分析。结果:本研究经检索并通过筛选后可得到山茱萸活性成分12个,与骨质疏松相关的靶点基因30个。并且得到GO功能富集中生物过程485个条目,细胞组分36个条目,分子功能58个条目。KEGG富集分析共映射出59条信号通路。结论:通过生物信息学及网络药理学揭示了山茱萸有效活性成分——多靶点基因–多通络治疗骨质疏松的分子作用机制。
Abstract: Objective: To explore the molecular network regulation mechanism of Cornus officinalis in osteoporosis, this study is based on network pharmacology and bioinformatics methods to screen effective active ingredients and potential targets of Cornus officinalis, then construct an active component-action target network diagram and protein-protein-interaction network (PPI) diagram of Cornus officinalis. Methods: The main active ingredients and potential targets of Cornus officinalis were retrieved and screened through the Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP). Target genes of osteoporosis were retrieved through the OMIM and Genecards databases. The R software was used to draw the Venn diagram which was about target genes of Cornus officinalis and osteoporosis. Perl software and Cytoscape 3.7.2 were used to construct the active ingredient-action target network diagram of Cornus officinalis. The PPI network was constructed through the STRING database, and the core genes of the PPI network were extracted using R software. And we used R language to analyse GO function and KEGG pathway. Results: After screening OB and DL in this study, 12 active ingredients of Cornus officinalis can be obtained. We found that there are 30 target genes related to osteoporosis among the active ingredient targets. In this study, there were 485 entries in the biological process, 36 entries in cell component analysis, and 58 entries in molecular function analysis. In addition, KEGG enrichment analysis has 59 signal pathways. Conclusion: Based on bioinformatics and network pharmacology, it revealed the molecular mechanism of Cornus officinalis effective active ingredient-multi-target gene-multi-channel network in the treatment of osteoporosis.
文章引用:宋慧芳, 贾秀娟. 基于网络药理学方法揭示山茱萸作用于骨质疏松的机制[J]. 临床医学进展, 2021, 11(4): 1794-1803. https://doi.org/10.12677/ACM.2021.114258

参考文献

[1] Maraka, S. and Kennel, K.A. (2015) Bisphosphonates for the Prevention and Treatment of Osteoporosis. BMJ, 351, h3783. [Google Scholar] [CrossRef] [PubMed]
[2] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-443.
[3] Yuan, L.Q., Xiao, L., Dan, X., Peng, Y.Q., Sheng, Z.F., Wu, X.P., et al. (2015) Epidemiology and Management of Osteoporosis in the People’s Republic of China: Current Perspectives. Clinical Interventions in Aging, 10, 1017-1033. [Google Scholar] [CrossRef
[4] 陶亚军. 骨质疏松药物治疗的研究进展[J]. 医学综述, 2016, 22(9): 1715-1718.
[5] 张倩, 王花欣, 王媛, 等. 中药防治绝经后骨质疏松症的研究进展[J]. 中国骨质疏松杂志, 2020, 26(7): 1083-1088.
[6] 中国老年学学会骨质疏松委员会中医药与骨病学科组. 中医药防治原发性骨质疏松症专家共识[J]. 糖尿病临床, 2016, 10(12): 559-564.
[7] 潘扬, 王天山. 植物山茱萸化学成分的研究概况[J]. 南京中医药大学学报, 1998(1): 61-62.
[8] 张志宏, 邢娜, 彭东辉, 王秋红, 匡海学. 中药抗骨质疏松作用及机制的研究进展[J]. 中国药房, 2021, 32(3): 374-379.
[9] 张华, 魏合伟, 冯新送, 等. 中医对原发性骨质疏松症的认识及辨证施治研究[J]. 中医正骨, 2001, 13(3): 606.
[10] 陈涛. 山茱萸水提液对骨质疏松模型小鼠骨形态学影响[J]. 天津药学, 2003(4): 5-6.
[11] Zeng, L.P., Xu, X.Z., Rao, H., et al. (2012) Regulation of β-Sitosterol in Duzhongye on Homeostasis of Bone Metabolism. Lishizhen Medicine and Materia Medica Research, 23, 1051-1053.
[12] Srivastava, S.,Toraldo, G., Weitzmann, M.N., Cenci, S.C. and Pacifici, R. (2001) Estrogen Decreases Osteoclast Formation by Down-Regulating Receptor Activator of nf-κb Ligand (Rankl)-Induced JNK Activation. Journal of Biological Chemistry, 276, 8836-8840. [Google Scholar] [CrossRef
[13] 和渝斌, 何冰娟, 刘立新, 等. 不同β受体阻滞药对老年男性原发性高血压骨质代谢的影响[J]. 临床药物治疗杂志, 2012(5):13-16.
[14] Pasco, J.A., Henry, M.J., Sanders, K.M., Kotowicz, M.A., Seeman, E. and Nicholson, G.C. (2004) β-Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis Study. Journal of Bone and Mineral Research, 19, 19-24. [Google Scholar] [CrossRef] [PubMed]
[15] 彭莉, 李双庆. β2肾上腺素能受体激动剂/拮抗剂对大鼠OB IGF-I受体mRNA表达的影响[J]. 中国骨质疏松杂志, 2014, 20(5): 490-494.
[16] Wong, R. and Rabie, A. (2010) Effect of Quercetin on Bone Formation. Journal of Orthopaedic Research, 26, 1061-1066. [Google Scholar] [CrossRef] [PubMed]
[17] 黄秋霞, 周后德, 杜巍, 等. 雌二醇和孕酮对人成骨细胞胰岛素受体底物基因表达的时间与剂量依赖性[J]. 中华老年医学杂志, 2005, 24(10): 775-778.
[18] Yuan, C.Q. and Ding, Z.H. (2002) Activation and Function of Caspases in Apoptosis. Progress in Physiology, 33, 220-224.
[19] Liu, J., Li, Y. and Geriatrics, D.O. (2015) Effects of Caspase Proteins and Bcl-2 Protein of Osteoblasts on Pathogenesis of Postmenopausal Osteoporosis. Chinese Journal of Joint Surgery (Electronic Edition), 9, 780-783.
[20] Qi, Z., Li, W., Jiang, L.T., et al. (2016) Effects of Bisphosphonates on the Expression of Bcl-2, Bax and Caspase-3 in Condylar Cartilage of Osteoporosis Rats. Chinese Journal of Tissue Engineering Research, 20, 3970-3976.
[21] Lane, N.E. and Lukert, B. (1998) The Science and Therapy of Glucocorticoid-Induced Bone Loss. Endocrinology and Metabolism Clinics of North America, 27, 465-483. [Google Scholar] [CrossRef
[22] 樊长萍, 侯建明. 原发性醛固酮增多症与骨质疏松症的相关性[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(2): 199-204.
[23] 李靖, 王全平. 细胞凋亡与骨质疏松关系的研究进展[J]. 中华骨科杂志, 2001, 21(5): 305-307.
[24] 谢肇, 李起鸿. 绝经后骨质疏松症的细胞凋亡及其调控机制[J]. 中华老年医学杂志, 2004, 23(6): 436-438.